Roger Michael Gendreau - Jun 27, 2025 Form 4 Insider Report for Dogwood Therapeutics, Inc. (DWTX)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Greg Duncan, Attorney-in-Fact
Stock symbol
DWTX
Transactions as of
Jun 27, 2025
Transactions value $
$0
Form type
4
Date filed
7/1/2025, 02:11 PM
Previous filing
Feb 28, 2024
Next filing
Dec 5, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gendreau Roger Michael CHIEF MEDICAL OFFICER C/O DOGWOOD THERAPEUTICS, INC., 44 MILTON AVENUE, ALPHARETTA /s/ Greg Duncan, Attorney-in-Fact 2025-07-01 0001826131

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DWTX Stock Option (right to buy) Award $0 +12.1K $0.00 12.1K Jun 27, 2025 Common Stock 12.1K $4.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests one-third on June 27, 2026 and 1/24th monthly thereafter.